D'Annunzio University is a public research university located in Chieti and Pescara, neighbouring cities in the region of Abruzzo, Italy.

During the past decade, G. d'Annunzio University conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 7 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "G. d'Annunzio University" #1 sponsor was "G. d'Annunzio University" with 16 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Novartis" with 3 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "G. d'Annunzio University" #1 collaborator was "Novartis Vaccines" with 3 trials as a collaborator, "Agenzia Italiana del Farmaco" with 2 trials as a collaborator, "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "CRESGE" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "G. d'Annunzio University" are "Gingival Recession" (4 trials), "Periodontal Bone Loss" (4 trials), "Periodontal Attachment Loss" (3 trials), "Advanced Non-Small Cell Lung Cancer" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "G. d'Annunzio University" in a lesser frequency.

Most popular intervention types in "G. d'Annunzio University" are "Drug" (23 trials), "Procedure" (10 trials), "Other" (5 trials), "Biological" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "fluorouracil" (3 trials), "Baricitinib" (2 trials), "Cladribine" (2 trials) and "Dulaglutide" (2 trials). Other intervention names were less common.

The vast majority of trials in "G. d'Annunzio University" are 46 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "G. d'Annunzio University". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in G. d'Annunzio University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in G. d'Annunzio University, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".

G. d'Annunzio University has several departments that took part in Clinical trials: "Division of Nephrology, University of "G. d'Annunzio"" - 4 trials, "Department of Medicine and Aging Sciences, University of Chieti" - 2 trials, "Universita' G. D'Annunzio; Dipartimento di Neuroscienze, Imaging e Scienze Cliniche" - 3 trials, "Department of Nephrology, University of Chieti" - 2 trials, "Department of Neuroscience, Imaging and Clinical Sciences" - 2 trials